KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neogenomics (NEO) Change in Working Capital (2016 - 2018)

Historic Change in Working Capital for Neogenomics (NEO) over the last 5 years, with Q4 2018 value amounting to $42.7 million.

  • Neogenomics' Change in Working Capital fell 1348.27% to $42.7 million in Q4 2018 from the same period last year, while for Dec 2018 it was $42.7 million, marking a year-over-year decrease of 1348.27%. This contributed to the annual value of $42.7 million for FY2018, which is 1348.27% down from last year.
  • Latest data reveals that Neogenomics reported Change in Working Capital of $42.7 million as of Q4 2018, which was down 1348.27% from $49.4 million recorded in Q4 2017.
  • In the past 5 years, Neogenomics' Change in Working Capital ranged from a high of $49.4 million in Q4 2017 and a low of $39.6 million during Q4 2016
  • Over the past 5 years, Neogenomics' median Change in Working Capital value was $42.7 million (recorded in 2018), while the average stood at $43.6 million.
  • In the last 5 years, Neogenomics' Change in Working Capital skyrocketed by 2472.92% in 2017 and then plummeted by 1348.27% in 2018.
  • Neogenomics' Change in Working Capital (Quarter) stood at $44.1 million in 2014, then decreased by 4.12% to $42.3 million in 2015, then fell by 6.37% to $39.6 million in 2016, then increased by 24.73% to $49.4 million in 2017, then fell by 13.48% to $42.7 million in 2018.
  • Its last three reported values are $42.7 million in Q4 2018, $49.4 million for Q4 2017, and $39.6 million during Q4 2016.